132 related articles for article (PubMed ID: 37445942)
1. Unraveling the Roles of miR-204-5p and HMGA2 in Papillary Thyroid Cancer Tumorigenesis.
Van Branteghem C; Augenlicht A; Demetter P; Craciun L; Maenhaut C
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445942
[TBL] [Abstract][Full Text] [Related]
2. miR-98-5p promotes apoptosis and inhibits migration and cell growth in papillary thyroid carcinoma through Bax/Caspase-3 by HMGA2.
Qiu K; Xie Q; Jiang S; Lin T
J Clin Lab Anal; 2020 Feb; 34(2):e23044. PubMed ID: 31670857
[TBL] [Abstract][Full Text] [Related]
3. miR-199b-5p-Stonin 2 axis regulates metastases and epithelial-to-mesenchymal transition of papillary thyroid carcinoma.
Ren L; Xu Y; Qin G; Liu C; Yan Y; Zhang H
IUBMB Life; 2019 Jan; 71(1):28-40. PubMed ID: 30325582
[TBL] [Abstract][Full Text] [Related]
4. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.
Fu S; Ma C; Tang X; Ma X; Jing G; Zhao N; Ran J
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34486645
[TBL] [Abstract][Full Text] [Related]
5. LncRNA HAGLROS contribute to papillary thyroid cancer progression by modulating miR-206/HMGA2 expression.
Zeng Z; Tang S; Chen L; Hou H; Liu Y; Li J
Aging (Albany NY); 2023 Dec; 15(24):14930-14944. PubMed ID: 38112616
[TBL] [Abstract][Full Text] [Related]
6. MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K/AKT pathway in papillary thyroid carcinoma.
Zheng T; Zhou Y; Xu X; Qi X; Liu J; Pu Y; Zhang S; Gao X; Luo X; Li M; Wang X; Dong L; Wang Y; Mao C
J Transl Med; 2022 Jan; 20(1):20. PubMed ID: 34991623
[TBL] [Abstract][Full Text] [Related]
7. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67.
Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096
[TBL] [Abstract][Full Text] [Related]
8. The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2.
Ding C; Shi T; Wu G; Man J; Han H; Cui Y
Bioengineered; 2022 Mar; 13(3):6629-6640. PubMed ID: 35213273
[TBL] [Abstract][Full Text] [Related]
9. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
[TBL] [Abstract][Full Text] [Related]
10. MiR-146b-5p Regulates the Expression of Long Noncoding RNA
Peng Y; Fang X; Yao H; Zhang Y; Shi J
Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601
[No Abstract] [Full Text] [Related]
11. NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma.
Yang C; Liu Z; Chang X; Xu W; Gong J; Chai F; Cui D
J Cell Biochem; 2020 Feb; 121(2):2009-2018. PubMed ID: 31692033
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-524-5p suppresses the progression of papillary thyroid carcinoma cells via targeting on FOXE1 and ITGA3 in cell autophagy and cycling pathways.
Liu H; Chen X; Lin T; Chen X; Yan J; Jiang S
J Cell Physiol; 2019 Aug; 234(10):18382-18391. PubMed ID: 30941771
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-150-5p affects cell proliferation, apoptosis, and EMT by regulation of the BRAF
Yan R; Yang T; Zhai H; Zhou Z; Gao L; Li Y
J Cell Biochem; 2018 Nov; 119(11):8763-8772. PubMed ID: 30126001
[TBL] [Abstract][Full Text] [Related]
14. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
15. Circ_0039411 promotes papillary thyroid carcinoma development through mediating the miR-423-5p/SOX4 signaling.
Wen X; Du J; Wang X
Int J Biol Markers; 2021 Dec; 36(4):10-20. PubMed ID: 34738852
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1.
Li R; Dong B; Wang Z; Jiang T; Chen G
Biomed Pharmacother; 2018 Jun; 102():988-995. PubMed ID: 29710554
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression.
Cai X; Zhao Z; Dong J; Lv Q; Yun B; Liu J; Shen Y; Kang J; Li J
Cell Death Dis; 2019 Feb; 10(3):184. PubMed ID: 30796202
[TBL] [Abstract][Full Text] [Related]
18. miR-200b/c-RAP1B axis represses tumorigenesis and malignant progression of papillary thyroid carcinoma through inhibiting the NF-κB/Twist1 pathway.
Zhou B; Xu J; Chen Y; Gao S; Feng X; Lu X
Exp Cell Res; 2020 Feb; 387(2):111785. PubMed ID: 31877303
[TBL] [Abstract][Full Text] [Related]
19. Expression of miR-31-5p affects growth, migration and invasiveness of papillary thyroid cancer cells.
Maggisano V; Capriglione F; Verrienti A; Celano M; Sponziello M; Pecce V; Russo D; Durante C; Bulotta S
Endocrine; 2023 Mar; 79(3):517-526. PubMed ID: 36474133
[TBL] [Abstract][Full Text] [Related]
20. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
